Priority platform

Peptide Lab Platform for guided discovery partnerships.

Metastate is now prioritizing the Peptide Lab Platform: a guided workflow for short-peptide discovery and partner-led validation, starting with GLP-1 secretion targets.

The public wedge is GLP-1 because it is concrete, assayable, and commercially relevant. Underneath that wedge is a broader peptide prioritization platform designed to narrow large candidate spaces into a validation-ready shortlist.

  • Generate and filter candidate peptides before wet-lab spend compounds.
  • Deliver explainable prioritization signals, not black-box rankings.
  • Work with validation partners through a guided demo and feedback loop.
Legacy consulting pages remain live, but Peptide Lab Platform is now the primary commercial path on the site.
Scientist in a laboratory
Structured peptide prioritization before assay spend.
Research team reviewing data
Guided partner demos with validation logic built in.
BSFZ seal TUBITAK logo

What Metastate is now prioritizing

A peptide-first platform company, with guided delivery rather than generic self-serve software.

We are not positioning Peptide Lab as another dashboard. The operating model is a guided platform engagement: Metastate does the computational narrowing, the partner brings the relevant assay context, and both sides close the loop around validation.

GLP-1 secretion is the first public application because it offers a concrete way to show the workflow. The broader platform logic is portable to other peptide-prioritization problems where the candidate space is large and experimental bandwidth is limited.

Computational outputs are framed as prioritization signals rather than biological proof. The goal is to improve decision quality before the next wet-lab round, not to overstate certainty.

Peptide Lab Platform delivers

  • Candidate shortlist with explicit scoring rationale.
  • Evidence map showing why candidates survived filtering.
  • Suggested validation package with controls and baselines.
  • Partner handoff covering failure modes and next branches.

Where peptide programs get stuck

Most teams do not need more candidates. They need a better way to eliminate weak ones before validation spend compounds.

Too many plausible peptides

Candidate generation is easy. Knowing which peptides are worth testing first is where time and budget disappear.

Weak handoff to validation

Teams reach the assay stage with rankings but no clear rationale, controls, or fallback plan when the first round is noisy.

Platform story is too abstract

Broad claims do not convert. A specific wedge like GLP-1 lets a platform story become concrete and commercially testable.

Start here

If you can run or coordinate peptide validation work, start with the Peptide Lab Platform. If you are here for upstream process, DOE, or broader discovery support, the legacy Metastate program pages remain available below.

Peptide first. Other programs remain available.

The platform page below is the main path. The rest of the site stays live for selected consulting and discovery engagements.

Peptide Lab Platform

Priority

Guided peptide discovery and validation-partner workflow, starting with GLP-1 secretion targets and expanding into broader peptide programs.

Best for: Assay-capable labs, ingredient teams, translational partners, and groups evaluating peptide candidate shortlists.

Engagement: Guided demos, partner discovery briefs, and validation-loop collaboration.

View platform page

Bioprocess Optimization Consulting

Secondary

Diagnose scale-up divergence, titer plateaus, and upstream bottlenecks before another expensive round.

Best for: Upstream PD, strain teams, tech transfer, scale-up divergence, and titer plateaus.

Engagement: Diagnostic sprints plus broader advisory support.

View page

Design of Experiments Consulting

Secondary

Design high-information experiments under real throughput, cost, and bioreactor-time constraints.

Best for: Teams running expensive loops who need clean factor selection and decision rules.

Engagement: Rapid engagement or embedded support.

View page

Synthetic Lethality Analysis

Discovery

Turn noisy screening signals into ranked validation plans and interpretable next experiments.

Best for: Discovery teams who need interpretable hypotheses, not just model output.

Engagement: Project-based.

View page

Personalized Metabolomics

Individual

A metabolomics snapshot translated into actionable hypotheses for lifestyle and intervention experiments.

Best for: Individuals and research teams running structured self experiments.

Engagement: Report plus optional follow-on.

View program

Sector-specific pages

Precision fermentation, CDMO tech transfer, biologics upstream teams, and industrial biotech pages remain available under the broader Programs hub.

Browse all programs

Proof and resources

The peptide path is backed by a public whitepaper, a clear platform page, and a published press update around the first wedge.

Peptide Lab Platform

The main commercial page: what the platform does, who it is for, and how partner validation fits into the workflow.

View platform page

Peptide Lab whitepaper

Public technical overview of the prioritization workflow and the validation questions it is built to support.

Open resource page

Whitepaper and patent update

Press post covering the public whitepaper release and the first patent filing around the platform framework.

Read update

How the workflow works

A guided loop that narrows candidate space before assay work starts.

Generate and frame

Start with the source material, the target biology, and the practical constraints around validation.

Filter and rank

Apply explainable scoring, structure-aware checks, and controls that reduce false confidence before wet-lab testing.

Close the validation loop

Hand off a shortlist, controls, and decision branches so the partner can turn assay output into the next concrete move.

What a partner gets

Every Peptide Lab engagement is meant to leave the partner with a validation-ready decision package, not a vague ranking.

  • Candidate shortlist. A narrowed set of peptides with explicit reasons for inclusion.
  • Evidence map. Which signals mattered, which did not, and where uncertainty remains.
  • Validation brief. Suggested controls, baselines, and assay logic for the first loop.
  • Handoff. A partner-facing walkthrough with next branches if the first results are noisy or mixed.

Press and milestones

Company updates, grants, talks, and major milestones.

View press archive

Request a Peptide Lab Platform demo.

Tell us what peptide or validation question you are working on. We will reply with fit, the best starting scope, and the minimum inputs needed for a useful first pass.

Tell us what you need

Peptide Lab Platform is the priority path, but we still route upstream, DOE, and discovery requests when there is a strong fit.